BAYN

Bayer AG PK

BAYRY.US bayer.com
14.09
-0.20 (-1.40%)
USD · OTCQX
52-week range
7.46
15.23
Trading at 85% of the 52-week range
Market Cap
56.23B
P/E Ratio
0.00
Forward P/E
10.58
Book Value
8.75
Div. Yield
0.22%
% Institutions
0.348%
% Insiders
0.00%

1 Year

+72.8%

3 Year

+3.4%

10 Year

-29.8%
Description

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Company Information

Company Name
Bayer AG PK
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
OTCQX
ISIN: US0727303028
CIK: 0000790075
CUSIP: 072730302
Currency: USD
Full Time Employees: 87,830
Phone: 49 214 30 1
Website: bayer.com
Fiscal Year End: December
Description:

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Address:

Kaiser-Wilhelm-Allee 1, Leverkusen, Germany, 51368

People

Directors & Officers

Name Title Year Born
Mr. William N. Anderson Chairman of the Management Board & CEO 1966
Mr. Stefan Oelrich President of the Pharmaceuticals Division & Member of the Board of Management 1968
Ms. Heike Prinz Chief Talent Officer, Labor Director & Member of Management Board 1964
Dr. Judith Hartmann CFO & Member of Management Board 1969
Mr. Rodrigo Santos Member of Management Board, Head of the Crop Science Division & President of Crop Science Division 1973
Mr. Julio Triana Member of Management Board & President of Consumer Health Division 1965
Mr. Alex Buschermohle Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division NA
Ms. Jana Marlen Ackermann Head of the Investor Relations 1984
Mr. Bill Dodero General Counsel and Senior VP of Law Patents & Compliance NA
Mr. Michael Preuss Head of Communications, Government Relations and Corporate Brand NA

Financial Highlights

Market Cap: $56.23B
EBITDA: $10.13B
PEG Ratio: $4.73
Book Value: $8.75
Dividend/Share: $0.11
Dividend Yield: 0.22%
Earnings/Share: $-0.51
Profit Margin: -3.83%
Operating Margin: 9.19%
ROA (TTM): 3.18%
ROE (TTM): -5.69%
Revenue (TTM): $45.38B
Revenue/Share (TTM): $11.55
Earnings Growth (YOY): 112.90%
Revenue Growth (YOY): 1.20%

Valuation Metrics

Enterprise Value: $89.69B
Trailing P/E: 0.00
Forward P/E: 10.58

Shares Statistics

Shares Outstanding: 3.93B
Shares Float: 3.93B
% Insiders: 0.00%
% Institutions: 0.348%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$45.58B
Cost of Goods Sold
adjust
$-18.80B
Gross Profit
subtotal
$26.78B
SG&A
adjust
$-14.71B
R&D
adjust
$-5.77B
Other Operating Expense
adjust
$-18.96B
Operating Income
subtotal
$6.14B
Other / Non-Operating Items
adjust
$-9.76B
Net Income
subtotal
$-3.62B

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BAYRY.US!